🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will assess the immunogenicity and safety of GlaxoSmithKline (GS...
Status
Completed
Location
Multiple Locations
Start Date
1999-01
Trial ID
NCT01457508
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The primary phase of this study is evaluating the safety of Hib-MenCY-TT va...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-09
Trial ID
NCT00345579
Pediacel™ is currently licensed in the UK for use as a 3 dose regimen for t...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT00287092
Treatments Being Tested
This protocol posting deals with objectives \& outcome measures of an exten...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-14
Trial ID
NCT00891176
This study evaluates the immunogenicity and consistency of 3 Hib-MenCY-TT v...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-02-22
Trial ID
NCT00289783
This protocol posting deals with objectives \& outcome measures of the exte...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-05
Trial ID
NCT00322335
This study evaluated the safety and immunogenicity of 3 formulations of Hib...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-03-01
Trial ID
NCT00127855
The purpose of this Phase IIIb study is to evaluate the immunogenicity, rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-12-01
Trial ID
NCT00586612
Treatments Being Tested
The purpose of this primary vaccination study is to evaluate the immunogeni...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00135486
Treatments Being Tested